Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesOral Phosphate Supplementation Corrects Hypophosphatemia and Normalizes Plasma FGF23 and 25-Hydroxyvitamin D3 Levels in Women with Chronic Metabolic Acidosis
Experimental and Clinical Endocrinology & Diabetes, 05/19/09
Domrongkitchaiporn S et al. - The CMA-induced hypophosphatemia was likely to initiate a negative feedback response, thereby leading to reduction in the plasma levels of hyperphosphaturic hormones, FGF23 and PTH. An increase in the plasma 1,25(OH)2D3 level, despite diminishing 25(OH)D3 storage pool, may help enhance the intestinal phosphate absorption. Oral phosphate supplementation abolished the effects of CMA on FGF23 and 25(OH)D3 levels, suggesting that the plasma phosphate concentration is the primary regulator of the plasma levels of these hormones during CMA.
Today in Acid-Base...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive Therapy
Archives of Internal Medicine, 09/30/09
Assessing acid–base disorders
Kidney International, 10/08/09
Impact of normal saline infusion on postoperative metabolic acidosis
Paediatric Anaesthesia, 10/07/09
Article Search
Sponsor